Syndecan-4 influences mammalian myoblast proliferation by modulating myostatin signalling and G1/S transition

FEBS Lett. 2018 Sep;592(18):3139-3151. doi: 10.1002/1873-3468.13227. Epub 2018 Sep 7.

Abstract

Myostatin, a TGF-β superfamily member, is a negative regulator of muscle growth. Here we describe how myostatin activity is regulated by syndecan-4, a ubiquitous transmembrane heparan sulfate proteoglycan. During muscle regeneration the levels of both syndecan-4 and promyostatin decline gradually after a sharp increase, concurrently with the release of mature myostatin. Promyostatin and syndecan-4 co-immunoprecipitate, and the interaction is heparinase-sensitive. ShRNA-mediated silencing of syndecan-4 reduces C2C12 myoblast proliferation via blocking the progression from G1- to S-phase of the cell cycle, which is accompanied by elevated levels of myostatin and p21(Waf1/Cip1), and decreases in cyclin E and cyclin D1 expression. Our results suggest that syndecan-4 functions as a reservoir for promyostatin regulating the local bioavailability of mature myostatin.

Keywords: myoblast; myostatin; syndecan-4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle*
  • Cell Line
  • Cell Proliferation*
  • Cyclin D1 / metabolism
  • Cyclin E / metabolism
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • G1 Phase
  • Mice
  • Myoblasts / cytology
  • Myoblasts / metabolism*
  • Myostatin / metabolism*
  • RNA Interference
  • Rats
  • S Phase
  • Signal Transduction
  • Syndecan-4 / genetics
  • Syndecan-4 / metabolism*

Substances

  • Cdkn1a protein, mouse
  • Cyclin E
  • Cyclin-Dependent Kinase Inhibitor p21
  • Myostatin
  • Syndecan-4
  • Cyclin D1